EPS for MEDNAX Inc (MD) Expected At $0.79

October 12, 2017 - By Nellie Frank

 EPS for MEDNAX Inc (MD) Expected At $0.79

Investors wait MEDNAX Inc (NYSE:MD) to report on October, 26. its quarterly earnings Wall Street analysts expect $0.79 earnings per share, down $0.28 or 26.17 % from last year’s $1.07 same quarter earnings. This translates into $74.57M profit for MD giving the stock a 13.48 P/E. This is assuming the current $0.79 EPS is accurate. MEDNAX Inc’s Wall Street analysts see -1.25 % negative EPS growth, taking into account the $0.80 EPS reproted in the previous quarter, About 1.01M shares traded. MEDNAX Inc (NYSE:MD) has declined 18.20% since October 13, 2016 and is downtrending. It has underperformed by 34.90% the S&P500.

MEDNAX Inc (NYSE:MD) Ratings Coverage

Among 14 analysts covering MEDNAX (NYSE:MD), 3 have Buy rating, 1 Sell and 10 Hold. Therefore 21% are positive. MEDNAX had 34 analyst reports since July 31, 2015 according to SRatingsIntel. The company was maintained on Tuesday, August 25 by Stifel Nicolaus. The firm has “Hold” rating by Robert W. Baird given on Thursday, October 5. The firm has “Buy” rating given on Friday, October 28 by Mizuho. On Friday, April 29 the stock rating was maintained by Mizuho with “Buy”. Mizuho initiated the stock with “Buy” rating in Wednesday, September 30 report. The rating was downgraded by Raymond James on Thursday, October 27 to “Mkt Perform”. The rating was maintained by Dougherty & Company with “Buy” on Friday, July 31. The firm has “Neutral” rating by Susquehanna given on Monday, March 7. The firm has “Hold” rating given on Thursday, May 25 by Stifel Nicolaus. Zacks downgraded the shares of MD in report on Monday, September 7 to “Hold” rating.

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The company has market cap of $4.02 billion. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital neonatal intensive care units , to babies born prematurely or with medical complications. It has a 13.59 P/E ratio. As of December 31, 2016, the Company had over 1,390 affiliated physicians providing anesthesia care to patients in connection with surgical and other procedures, as well as pain management.

More news for MEDNAX Inc (NYSE:MD) were recently published by: Businesswire.com, which released: “MEDNAX Announces Acquisition of Leading Connecticut Radiology Practice” on September 28, 2017. Businesswire.com‘s article titled: “MEDNAX Addresses National Opioid Use and Abuse” and published on October 10, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: